Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamera J Corte

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Annals of the American Thoracic Society|June 30, 2026
Co-designing a Palliative Care Referral Tool for Patients with Fibrosing Interstitial Lung DiseaseKah Yee Tham, Mymy Tran, Susanne E Webster, et al.
Respirology (Carlton, Vic.)|March 30, 2019
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testingAndrew Burgess, Ken Goon, John D Brannan, et al.
Respirology (Carlton, Vic.)|August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaHelen E Jo, Lauren K Troy, Gregory Keir, et al.
Respirology (Carlton, Vic.)|July 11, 2023
Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from AustraliaQiang Zheng, Ingrid A Cox, Lucy Leigh, et al.
BMC Pulmonary Medicine|May 5, 2019
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF RegistryHelen E Jo, Tamera J Corte, Ian Glaspole, et al.
The European Respiratory Journal|February 25, 2017
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Christopher Grainge, et al.
Respirology (Carlton, Vic.)|July 19, 2016
Clinical impact of the interstitial lung disease multidisciplinary serviceHelen E Jo, Ian N Glaspole, Kovi C Levin, et al.
Respirology (Carlton, Vic.)|January 11, 2024
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revisionJohn A Mackintosh, Gregory Keir, Lauren K Troy, et al.
Respirology (Carlton, Vic.)|March 25, 2020
Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluationGabriella Tikellis, Joanna Y T Lee, Tamera J Corte, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
American Journal of Respiratory and Critical Care Medicine|March 29, 2008
Interstitial lung disease in systemic sclerosis: a simple staging systemNicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, et al.
Annals of the American Thoracic Society|June 30, 2026
Co-designing a Palliative Care Referral Tool for Patients with Fibrosing Interstitial Lung DiseaseKah Yee Tham, Mymy Tran, Susanne E Webster, et al.
Respirology (Carlton, Vic.)|March 30, 2019
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testingAndrew Burgess, Ken Goon, John D Brannan, et al.
Respirology (Carlton, Vic.)|August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation AustraliaHelen E Jo, Lauren K Troy, Gregory Keir, et al.
Respirology (Carlton, Vic.)|July 11, 2023
Long-term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from AustraliaQiang Zheng, Ingrid A Cox, Lucy Leigh, et al.
BMC Pulmonary Medicine|May 5, 2019
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF RegistryHelen E Jo, Tamera J Corte, Ian Glaspole, et al.
The European Respiratory Journal|February 25, 2017
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis RegistryHelen E Jo, Ian Glaspole, Christopher Grainge, et al.
Respirology (Carlton, Vic.)|July 19, 2016
Clinical impact of the interstitial lung disease multidisciplinary serviceHelen E Jo, Ian N Glaspole, Kovi C Levin, et al.
Respirology (Carlton, Vic.)|January 11, 2024
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revisionJohn A Mackintosh, Gregory Keir, Lauren K Troy, et al.
Respirology (Carlton, Vic.)|March 25, 2020
Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluationGabriella Tikellis, Joanna Y T Lee, Tamera J Corte, et al.
Pageof 16